908 Devices Secures $17.5M Series E Funding to Advance Mass Spectrometry-Based Chemical Detection Tools

VCBeat (WeChat Official Account: vcbeat) has learned that on April 29, 908 Devices, a pioneer in chemical and biomolecular analysis equipment, announced the completion of a $17.5 million Series E financing round. Thanks to this round of financing, 908 Devices’ total funding has reached $70 million, making it the best-capitalized newcomer in the multi-billion-dollar mass spectrometry market. The proceeds from the financing will be used to enhance the capabilities of the company’s MX908 and ZipChip product lines.

This round of financing was led by Northpond Ventures, a global venture capital firm focused on technology investments, with participation from Sands Capital Ventures, Arch Venture Partners, Razor’s Edge Ventures, Saudi Aramco Energy Ventures, Schlumberger, Tao Capital Partners, and Casdin Capital. Additionally, Sharon Kedar, co-founder of Northpond, will join the board of directors of 908 Devices.

908 Devices was founded in Boston, Massachusetts, in 2012, primarily manufacturing handheld chemical detection tools for mass spectrometry. Mass spectrometry is a well-established analytical technique used to measure the mass of charged molecules. This technology is mainly applied in various fields, including food safety, biotechnology, clinical diagnostics, and industrial process control.

ZipChip Device (Image from the official website)

ZipChip is a front-end separation device designed to enhance mass spectrometry analysis. It is currently being utilized in the research and development of critical biotherapeutic drugs and has been adopted by the top ten biopharmaceutical companies worldwide. ZipChip employs a cutting-edge combination of capillary electrophoresis (CE) and electrospray ionization (ESI), enabling the measurement of multiple critical quality attributes (CQAs) in a single run. It facilitates rapid and efficient analysis of even the most challenging samples, addressing complex issues that other technologies cannot resolve.

MX908 Device (Image from the official website)

The MX908 is a rugged, handheld chemical detection device used by elite responders worldwide to conduct detection tasks for chemicals, explosives, priority drugs, and hazardous materials, such as trace-level detection of fentanyl, synthetic opioids, and other priority chemical threat agents. The MX908 offers trace-level threat detection and identification selectivity, delivering real-time, actionable intelligence within seconds.

Dr. Kevin J. Knopp, CEO and Co-Founder of 908 Devices, stated, “The tools developed by 908 Devices are being widely adopted in the life sciences and on-site forensics markets. We take great pride in the support and trust of our investors. The newly injected capital will be used to deepen application support and expand the capabilities of our MX908 and ZipChip product lines. 908 Devices will also accelerate the development of other tools, including a brand-new life sciences instrument that we are preparing to launch later this year.”

“Sharon Kedar, Co-Founder of Northpond Ventures, stated, ‘We believe that 908 Devices holds a unique position in the life sciences sector. We are impressed by their product portfolio, innovation roadmap, and the market potential of their new products. We are delighted to join a talented team and make positive contributions to their continued growth.’”

Northpond Ventures, established in Bethesda, Maryland, in 2018, is a science-driven venture capital firm whose investment activities are primarily focused on healthcare-related sectors, including life sciences and medical technologies.

Sands Capital Ventures, based in Arlington, Virginia, USA, is a venture capital and growth equity investment firm that invests in companies at all stages in the fields of biotechnology and enterprise software.

Arch Venture Partners, established in 1986 in Illinois, USA, is a venture capital firm. The firm primarily invests in companies within the healthcare and clean energy sectors, having invested in over 120 companies with total assets under management amounting to $1.9 billion.

Razor’s Edge Ventures was established in Reston, Virginia, in March 2011. The company invests in and collaborates with private technology companies to jointly serve the national security market.

Saud Aramco Energy Ventures was established in Saudi Arabia in April 2012 as the corporate venture capital subsidiary of Saudi Aramco. As a world-leading integrated energy company, Saudi Aramco is committed to investing in startups and high-growth enterprises globally.

Schlumberger is the world’s leading integrated energy company. The company employs approximately 100,000 people from more than 140 countries. Schlumberger provides integrated oil and gas recovery solutions for the oil and gas industry, covering everything from exploration to production, and from pore to pipeline.

Tao Capital Partners was founded in 2002 in San Francisco, California, primarily investing in technology with positive impact, including alternative energy and transportation, healthcare, education, and real estate businesses.

Casdin Capital was founded in New York, United States, in 2011 as an investment firm focused on the life sciences and healthcare industries. The company primarily invests in enterprises during their early-stage startup and later-stage development phases. To date, Casdin Capital has made 37 investments, predominantly concentrated in the biotechnology sector.

(Compiled by: Li Chengping)